Health Catalyst, Inc. (HCAT)
1.69
-0.05
(-2.87%)
USD |
NASDAQ |
Oct 23, 16:00
1.695
0.00 (0.00%)
After-Hours: 20:00
Health Catalyst Enterprise Value : 192.61M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 192.61M |
| October 22, 2026 | 196.34M |
| October 21, 2026 | 196.34M |
| October 20, 2026 | 197.09M |
| October 19, 2026 | 194.10M |
| October 16, 2026 | 195.22M |
| October 15, 2026 | 200.82M |
| October 14, 2026 | 196.34M |
| October 13, 2026 | 196.34M |
| October 12, 2026 | 197.09M |
| October 09, 2026 | 198.58M |
| October 08, 2026 | 197.09M |
| October 07, 2026 | 197.83M |
| October 06, 2026 | 198.58M |
| October 05, 2026 | 197.83M |
| October 02, 2026 | 197.09M |
| October 01, 2026 | 193.36M |
| September 30, 2026 | 195.59M |
| September 29, 2026 | 197.09M |
| September 28, 2026 | 198.58M |
| September 25, 2026 | 196.34M |
| September 24, 2026 | 196.34M |
| September 23, 2026 | 194.85M |
| September 22, 2026 | 207.53M |
| September 21, 2026 | 201.56M |
| Date | Value |
|---|---|
| September 18, 2026 | 200.07M |
| September 17, 2026 | 200.82M |
| September 16, 2026 | 195.59M |
| September 15, 2026 | 194.85M |
| September 14, 2026 | 202.31M |
| September 11, 2026 | 193.36M |
| September 10, 2026 | 195.59M |
| September 09, 2026 | 195.59M |
| September 08, 2026 | 193.36M |
| September 04, 2026 | 192.61M |
| September 03, 2026 | 194.10M |
| September 02, 2026 | 192.61M |
| September 01, 2026 | 194.10M |
| August 31, 2026 | 188.88M |
| August 28, 2026 | 185.15M |
| August 27, 2026 | 185.15M |
| August 26, 2026 | 185.15M |
| August 25, 2026 | 184.40M |
| August 24, 2026 | 185.15M |
| August 21, 2026 | 180.67M |
| August 20, 2026 | 188.13M |
| August 19, 2026 | 192.61M |
| August 18, 2026 | 194.10M |
| August 17, 2026 | 193.36M |
| August 14, 2026 | 204.55M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LataMed AI Corp. | 8.893M |
| SCWorx Corp. | -1.068M |
| GoodRx Holdings, Inc. | 1.447B |
| Claritev Corp. | 5.069B |
| iSpecimen, Inc. | -2.930M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -40.54M |
| Revenue (Quarterly) | 70.49M |
| Total Expenses (Quarterly) | 111.02M |
| EPS Diluted (Quarterly) | -0.5481 |
| Gross Profit Margin (Quarterly) | 34.67% |
| Profit Margin (Quarterly) | -57.51% |
| Earnings Yield | -217.5% |
| Normalized Earnings Yield | -94.85 |